An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial ...
An artificial intelligence system that operates like a collaborative team of medical experts could accelerate clinical trial design, one of the most difficult steps in drug development, according to a ...
On June 22, 2026, the U.S. Department of Health and Human Services (HHS) announced the launch of Operation TrialBlazer, a coordinated effort ...
TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...
Delve into the hidden innovation system of drug repurposing. When patents expire and commercial value fades, a new wave of ...
Insilico Medicine ("Insilico," HKEX: 3696), a clinical-stage biotechnology company powered by generative AI, today announced the initiation of the Phase III clinical trial for Rentosertib, its ...
Some of the earliest real-money online casinos offered only a small selection of games, with InterCasino often cited as ...
FDA’s PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell ...
Medicare previously covered GLP-1s only if the beneficiary also had a condition such as diabetes, sleep apnea, high blood ...
Daily consumption of a specific strain of maitake mushroom might help older adults preserve their memory and cognitive ...
Iran had reportedly pressed Buehler about the matter in the immediate aftermath of the La Belle bombing and subsequent ...
FDA's PDUFA goal date is November 1, 2026If approved, mitapivat is positioned to become the first oral PK activator for patients with sickle cell disease CAMBRIDGE, Mass., July 07, 2026 (GLOBE NEWSWIR ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results